The Investment Program—funded through the PR Campania ERDF 2021-2027, PR Campania ESF+ 2021-2027, 2014-2020 Complementary Operational Plan (POC), and SME Fund returns (pursuant to Regional Government Resolutions/D.G.R. No. 661/2022, 157/2023, and 98/2024)—aims to expand and modernize the existing production unit, develop a new nanotechnology for production purposes, and implement a training plan for the qualification and upskilling of human resources.
The investment program is divided into three categories: A) productive investment, B) research and development project, and C) training plan.
• Productive Investment: The company intends to carry out structural works to functionally optimize the production site and subsequently proceed with the purchase of machinery, plants, and production equipment. This is intended to increase production capacity and modernize the facility.
• Research and Development Project: A molecule will be developed using new nanotechnologies for production purposes.
• Training Plan: Courses will be provided to bridge the gaps identified during the training needs analysis. These will focus on topics related to the R&D project, the strengthening of the company’s overall competitive positioning, and commercial development in foreign markets.
This investment program will enable an increase in the company’s level of innovation and the strengthening of the competitive advantage acquired in its reference sector, where “innovation” plays a strategic role in competition.
Development of new medical devices for various therapeutic areas, including acute and chronic skin lesions, lesions of the ocular, oral, vaginal, and rectal mucous membranes, burns;
Requalification of a part of the industrial facility located in the Municipality of Naples and purchase of plants and machinery to increase production volumes”